Margaret Daly

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 283 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Comparative study of electronic vs. paper VAS ratings: a randomized, crossover trial using healthy volunteers

Robert N. Jamison, Richard H. Gracely, Stephen A. Raymond et al. · Pain · 2002 · 210 citations

Nursing, Behavioral Sciences, Psychology +17

Assessment of Postoperative Pain Management: Patient Satisfaction and Perceived Helpfulness

Robert N. Jamison, Mitchell J. Ross, Phyllis Hoopman et al. · Clinical Journal of Pain · 1997 · 166 citations

Medicine, Orthopedic Surgery, Surgery +17

A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.

Andrew J. Friedman, Margaret Daly, Mary Juneau-Norcross et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 124 citations

Medicine, Endocrinology, Gynecology +17

Endocrinology: Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen—progestin or progestin ‘add-back’ for 2 years

Andrew J. Friedman, Margaret Daly, Mary Juneau-Norcross et al. · Human Reproduction · 1994 · 112 citations

Pharmacy, Endocrinology, Pharmacotherapy +17